Basic information Safety Supplier Related

daprodustat,GSK1278863

Basic information Safety Supplier Related

daprodustat,GSK1278863 Basic information

Product Name:
daprodustat,GSK1278863
Synonyms:
  • daprodustat,GSK1278863
  • GSK1278863
  • Daprodustat
  • 2-(1,3-dicyclohexyl-2,4,6-trioxohexahydropyrimidine-5-carboxamido)acetic acid
  • N-[(1,3-Dicyclohexylhexahydro-2,4,6-trioxo-5-pyrimidinyl)carbonyl]glycine
  • GSK1278863; GSK 1278863; GSK-1278863; DAPRODUSTAT
  • 2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acid
  • GSK1278863,daprodustat
CAS:
960539-70-2
MF:
C19H27N3O6
MW:
393.43
EINECS:
691-659-9
Product Categories:
  • API
Mol File:
960539-70-2.mol
More
Less

daprodustat,GSK1278863 Chemical Properties

Melting point:
237-241oC
Density 
1.359±0.06 g/cm3(Predicted)
storage temp. 
Refrigerator
solubility 
Chloroform (Slightly), DMSO (Slightly)
pka
3.44±0.10(Predicted)
form 
Solid
color 
White to Off-White
More
Less

daprodustat,GSK1278863 Usage And Synthesis

Uses

Daprodustat is a novel HIF (Hypoxia inducible factor)-prolyl hydroxylase inhibitor.

Biological Activity

daprodustat (gsk1278863) is a hif-prolyl hydroxylase inhibitor.hypoxia stimulates erythropoietin (epo) release through accumulation of hypoxia-inducible factor 1α (hif-1α), resulting in an increase of erythrocyte production by the bone marrow. hif-prolyl hydroxylase inhibitors have been used to selectively activate the phd-signaling pathway, leading to the stabilization of hifα subunits, which can affect the transcription of hif-responsive genes.

in vitro

in-vitro biotransformation data indicated that gsk1278863 was primarily metabolized by cyp2c8 [1].

References

[1] hara k,takahashi n,wakamatsu a,caltabiano s. pharmacokinetics, pharmacodynamics and safety of single, oral doses of gsk1278863, a novel hif-prolyl hydroxylase inhibitor, in healthy japanese and caucasian subjects. drug metab pharmacokinet.2015 dec;30(6):410-8.
[2] brigandi ra,johnson b,oei c,et al. a novel hypoxia-inducible factor-prolyl hydroxylase inhibitor (gsk1278863) for anemia in ckd: a 28-day, phase 2a randomized trial. am j kidney dis.2016 jun;67(6):861-71.

daprodustat,GSK1278863Supplier

Shanghai Famo Bio-chemical Technology Company Ltd. Gold
Tel
+862136680027 15800370750
Email
sales@famobiotech.com
Chengdu Yuyang High-tech Development Co., Ltd. Gold
Tel
0086-13852538605 13308012069
Email
13308012069@189.cn
S.Z. PhyStandard Bio-Tech. Co., Ltd. Gold
Tel
0755-4000505016 13380397412
Email
3001272453@qq.com
Jinan Guoding Pharmaceutical Technology Co., Ltd. Gold
Tel
13153106106
Email
sales@guodingpharma.com
Shanghai Xinlitai Pharmaceutical Co. , Ltd. Gold
Tel
18616665298
Email
wenjie.li@bocimed.com